{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:16:09Z","timestamp":1788297369560,"version":"build-2803163510"},"reference-count":253,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jsbmb.2025.106766","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T09:15:41Z","timestamp":1745572541000},"page":"106766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review"],"prefix":"10.1016","volume":"251","author":[{"given":"Refik","family":"Servi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan Faz\u0131l","family":"Akko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-8624","authenticated-orcid":false,"given":"S\u00fcleyman","family":"Servi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2025.106766_bib1","series-title":"Neuroactive steroids in brain function, behavior and neuropsychiatric disorders","article-title":"Neurosteroids in the Aging Brain","author":"Strous","year":"2008"},{"key":"10.1016\/j.jsbmb.2025.106766_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(01)46057-0","article-title":"Neurosteroids: beginning of the story","volume":"46","author":"Baulieu","year":"2001","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jsbmb.2015.09.030","article-title":"Neurosteroids and potential therapeutics: focus on pregnenolone","volume":"160","author":"Vall\u00e9e","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-0102(96)81278-8","article-title":"Roles of steroid hormones and their receptors in structural organization in the nervous system","volume":"24","author":"Kawata","year":"1995","journal-title":"Neurosci. Res."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/biom14080941","article-title":"Role of neuroactive steroids in health and disease","volume":"14","author":"Melcangi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jsbmb.2025.106766_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2011.00050","article-title":"Neuroprotective actions of neurosteroids","volume":"2","author":"Borowicz","year":"2011","journal-title":"Front. Endocrinol. (Lausanne"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2025.106766_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41398-023-02514-2","article-title":"Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder","volume":"13","author":"Cutler","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106766_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","article-title":"Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance","volume":"246","author":"Sears","year":"2021","journal-title":"Exp. Biol. Med (Maywood)."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/antiox11030501","article-title":"Superoxide radicals in the execution of cell death","volume":"11","author":"Fujii","year":"2022","journal-title":"Antioxid. (Basel)"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.62476\/abes9216","article-title":"H\u0131stolog\u0131cal exam\u0131nat\u0131on of ret\u0131nal funct\u0131on and the effects of curcuma longa on memory correct\u0131on in exper\u0131mental olfactory bulbectomy rat models","volume":"9","author":"Gashimova","year":"2024","journal-title":"Adv. Biol. Earth Sci."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.62476\/abes9196","article-title":"The saffron effects on the dynamics of experimental epilepsy","volume":"9","author":"Miryusifova","year":"2024","journal-title":"Adv. Biol. Earth Sci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells14040276","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jsbmb.2025.106766_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jsbmb.2025.106766_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100788","article-title":"Neurosteroids as regulators of neuroinflammation","volume":"55","author":"Yilmaz","year":"2019","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.jsbmb.2025.106766_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2011.04.010","article-title":"Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis","volume":"191","author":"Luchetti","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1570159X16666180911124605","article-title":"Neuroprotective strategies for neurological disorders by natural products: an update","volume":"17","author":"Rehman","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib19","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/molecules15053517","article-title":"Neuroprotective herbs and foods from different traditional medicines and diets","volume":"15","author":"Iriti","year":"2010","journal-title":"Molecules"},{"issue":"100","key":"10.1016\/j.jsbmb.2025.106766_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jsbmb.2025.106766_bib21","first-page":"179","article-title":"Chapter Six - Neuroprotective Natural Products","volume":"55","author":"Subrata","year":"2020"},{"key":"10.1016\/j.jsbmb.2025.106766_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbi.2024.10.007","article-title":"Frontiers of neurodegenerative disease treatment: targeting immune cells in brain border regions","volume":"123","author":"Satyanarayanan","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"14","key":"10.1016\/j.jsbmb.2025.106766_bib23","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.3390\/ijms23147965","article-title":"Investigating the role of GABA in neural development and disease using mice lacking GAD67 or VGAT genes","volume":"23","author":"Bolneo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib24","first-page":"342","article-title":"The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies","volume":"3","author":"Sienes Bailo","year":"2022","journal-title":"Adv. Lab. Med."},{"key":"10.1016\/j.jsbmb.2025.106766_bib25","series-title":"Neuroactive steroids in brain function, behavior and neuropsychiatric disorders","article-title":"Steroid Metabolism in Glial Cells","author":"Melcangi","year":"2008"},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib26","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa120","article-title":"Androgen therapy in neurodegenerative diseases","volume":"4","author":"Bianchi","year":"2020","journal-title":"J. Endocr. Soc."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/156720507783018262","article-title":"Regeneration in a degenerating brain: potential of allopregnanolone as a neuroregenerative agent","volume":"4","author":"Wang","year":"2007","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2009.00118.x","article-title":"Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials","volume":"16","author":"Ritsner","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib29","first-page":"166","article-title":"Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease","volume":"23","author":"Mehdizadeh","year":"2019","journal-title":"Physiol. Pharm."},{"key":"10.1016\/j.jsbmb.2025.106766_bib30","series-title":"Neuroactive steroids in brain function, behavior and neuropsychiatric disorders","article-title":"Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders","author":"Ritsner","year":"2008"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001051","article-title":"Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis","volume":"9","author":"Lazaridis","year":"2011","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11357-009-9113-4","article-title":"Dehydroepiandrosterone and age-related cognitive decline","volume":"32","author":"Sorwell","year":"2010","journal-title":"Age (Dordr. )"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000525677","article-title":"Progestogen-mediated neuroprotection in central nervous system disorders","volume":"113","author":"Bassani","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/aps.2013.160","article-title":"The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.brainresrev.2007.06.012","article-title":"Progesterone exerts neuroprotective effects after brain injury","volume":"57","author":"Stein","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jsbmb.2025.106766_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsbmb.2014.09.001","article-title":"Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection","volume":"146","author":"Guennoun","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10571-021-01118-y","article-title":"Progesterone and allopregnanolone neuroprotective effects in the wobbler mouse model of amyotrophic lateral sclerosis","volume":"42","author":"De Nicola","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/nbdi.2002.0564","article-title":"Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease","volume":"11","author":"Gonzalez Deniselle","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/1673-5374.155417","article-title":"Progesterone: a universal stimulus for neuronal cells?","volume":"10","author":"Theis","year":"2015","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib40","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-023-40800-1","article-title":"Structural insights into opposing actions of neurosteroids on GABA-A receptors","volume":"14","author":"Legesse","year":"2023","journal-title":"Nat. Commun."},{"issue":"2-3","key":"10.1016\/j.jsbmb.2025.106766_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2004.09.003","article-title":"Role of neurosteroids in catamenial epilepsy","volume":"62","author":"Reddy","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jsbmb.2025.106766_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2022.100502","article-title":"Allopregnanolone: regenerative therapeutic to restore neurological health","volume":"21","author":"Hernandez","year":"2022","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.jsbmb.2025.106766_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.931536","article-title":"Normal aging induces changes in the brain and neurodegeneration progress: review of the structural, biochemical, metabolic, cellular, and molecular changes","volume":"14","author":"Lee","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib44","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1210\/endo.140.8.6907","article-title":"Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain","volume":"140","author":"Zwain","year":"1999","journal-title":"Endocrinology"},{"issue":"51","key":"10.1016\/j.jsbmb.2025.106766_bib45","doi-asserted-by":"crossref","first-page":"21110","DOI":"10.1073\/pnas.1210804109","article-title":"Possible role of pineal allopregnanolone in Purkinje cell survival","volume":"109","author":"Haraguchi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsbmb.2025.106766_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fncel.2017.00024","article-title":"Glial cells and their function in the adult brain: a journey through the history of their ablation","volume":"11","author":"J\u00e4kel","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib47","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/cells8111424","article-title":"Oligodendrocytes in development, myelin generation and beyond","volume":"8","author":"Kuhn","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-0102(99)00132-7","article-title":"Novel brain function: biosynthesis and actions of neurosteroids in neurons","volume":"36","author":"Tsutsui","year":"2000","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/187152406776056555","article-title":"Neurosteroids in the brain neuron: Biosynthesis, action and medicinal impact on neurodegenerative disease","volume":"6","author":"Tsutsui","year":"2006","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106766_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.665795","article-title":"The role of astrocytes in the neurorepair process","volume":"9","author":"Chiareli","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fendo.2011.00061","article-title":"Biosynthesis, mode of action, and functional significance of neurosteroids in the purkinje cell","volume":"2","author":"Tsutsui","year":"2011","journal-title":"Front. Endocrinol. (Lausanne"},{"key":"10.1016\/j.jsbmb.2025.106766_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fncel.2014.00118","article-title":"Biosynthesis and biological action of pineal allopregnanolone","volume":"8","author":"Tsutsui","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"16","key":"10.1016\/j.jsbmb.2025.106766_bib53","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1523\/JNEUROSCI.21-16-06221.2001","article-title":"Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis","volume":"21","author":"Sakamoto","year":"2001","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.conb.2010.07.002","article-title":"Microglia dynamics and function in the CNS","volume":"20","author":"Parkhurst","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2741\/s433","article-title":"Ageing, neuroinflammation and neurodegeneration","volume":"7","author":"Ward","year":"2015","journal-title":"Front. Biosci. (Sch. Ed."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsbmb.2025.106766_bib57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib59","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2010-1828","article-title":"Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia","volume":"96","author":"Sahakitrungruang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2-3","key":"10.1016\/j.jsbmb.2025.106766_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12035-008-8024-1","article-title":"Neurosteroids in the Purkinje cell: biosynthesis, mode of action and functional significance","volume":"37","author":"Tsutsui","year":"2008","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib61","first-page":"49","article-title":"Neurosteroids in the cerebellar Purkinje neuron and their actions (review)","volume":"4","author":"Tsutsui","year":"1999","journal-title":"Int. J. Mol. Med."},{"issue":"28","key":"10.1016\/j.jsbmb.2025.106766_bib62","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1523\/JNEUROSCI.0710-07.2007","article-title":"Mode of action and functional significance of estrogen-inducing dendritic growth, spinogenesis, and synaptogenesis in the developing Purkinje cell","volume":"27","author":"Sasahara","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jsbmb.2025.106766_bib64","series-title":"Hydroxysteroid Dehydrogenases\u2013Localization, Function and Regulation in the Testis","author":"Kotula-Balak","year":"2012"},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2002-0050","article-title":"Molecular biology of the 3\u03b2-hydroxysteroid dehydrogenase\/\u03945-\u03944 isomerase gene family","volume":"26","author":"Simard","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2025.106766_bib66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.mie.2023.04.002","article-title":"Approaches to assessing 3\u03b2-hydroxysteroid dehydrogenase-1","volume":"689","author":"Alyamani","year":"2023","journal-title":"Methods Enzym."},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106766_bib67","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1021\/acscatal.1c00759","article-title":"Enzymatic Hydroxylations of sp3-Carbons","volume":"11","author":"M\u00fcnch","year":"2021","journal-title":"ACS Catal."},{"key":"10.1016\/j.jsbmb.2025.106766_bib68","series-title":"Handbook of neurochemistry and molecular neurobiology","article-title":"Cytochrome P450 Reactions in the Human Brain","author":"Haining","year":"2007"},{"issue":"Pt A","key":"10.1016\/j.jsbmb.2025.106766_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","article-title":"Steroid 17-hydroxylase and 17, 20-lyase deficiencies, genetic and pharmacologic","volume":"165","author":"Auchus","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib70","series-title":"Encyclopedia of Toxicology","first-page":"449","article-title":"Cytochrome P450","author":"Karanpreet","year":"2024"},{"issue":"13","key":"10.1016\/j.jsbmb.2025.106766_bib71","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.3390\/ijms21134812","article-title":"Steroids and Alzheimer's disease: changes associated with pathology and therapeutic potential","volume":"21","author":"Akwa","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib72","series-title":"The ovary","first-page":"83","article-title":"Chapter 5 - Organization of Ovarian Steroidogenic Cells and Cholesterol Metabolism","author":"Strauss","year":"2019"},{"key":"10.1016\/j.jsbmb.2025.106766_bib73","series-title":"Hormones","first-page":"27","article-title":"Chapter 2-Steroid Hormones: Chemistry, Biosynthesis, And Metabolism","author":"Norman","year":"2015"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib74","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/JME-16-0013","article-title":"Novel mechanisms for DHEA action","volume":"56","author":"Prough","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib75","series-title":"Hormones, brain and behavior","first-page":"59","article-title":"4.02 - Disorders of Sex Development in Males: Molecular Genetics, Epigenetics, Gender Identity, and Cognition","author":"Zhu","year":"2017"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jox15020044","article-title":"Brain Cytochrome P450: navigating Neurological Health and Metabolic Regulation","volume":"15","author":"Durairaj","year":"2025","journal-title":"J. Xenobiot."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2008.07.004","article-title":"Neurosteroids as modulators of neurogenesis and neuronal survival","volume":"19","author":"Charalampopoulos","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1389200223666220401093833","article-title":"Insights into interactions of human Cytochrome P450 17A1: a review","volume":"23","author":"Singh","year":"2022","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jsbmb.2025.106766_bib79","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/B978-0-12-800095-3.00013-4","article-title":"Environmental pollutants and hydroxysteroid dehydrogenases","volume":"94","author":"Ye","year":"2014","journal-title":"Vitam. Horm."},{"issue":"1-6","key":"10.1016\/j.jsbmb.2025.106766_bib80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0960-0760(99)00038-2","article-title":"Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3alpha-hydroxysteroid dehydrogenase","volume":"69","author":"Penning","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106766_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2010.08.003","article-title":"Selective inhibition of human 3\u03b2-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancer","volume":"125","author":"Thomas","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib82","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","article-title":"A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer","volume":"154","author":"Chang","year":"2013","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib83","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1210\/mend-5-8-1147","article-title":"Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase\/delta 5-delta 4-isomerase in human adrenals and gonads","volume":"5","author":"Rh\u00e9aume","year":"1991","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib84","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0040-22.2022","article-title":"The mitochondrial enzyme 17\u03b2HSD10 modulates ischemic and amyloid-\u03b2-induced stress in primary mouse astrocytes","volume":"9","author":"Metodieva","year":"2022","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JAD-142898","article-title":"Levels of 17\u03b2-hydroxysteroid dehydrogenase type 10 in cerebrospinal fluid of people with mild cognitive impairment and various types of dementias","volume":"48","author":"Kristofikova","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0039-128X(96)00167-5","article-title":"Structure and function of 3 alpha-hydroxysteroid dehydrogenase","volume":"62","author":"Penning","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2025.106766_bib87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","article-title":"Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise","volume":"113","author":"Irwin","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib88","first-page":"281","article-title":"Molecular endocrinology of hydroxysteroid dehydrogenases","volume":"18","author":"Penning","year":"1997","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib89","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/npp.2017.13","article-title":"The Neurosteroidogenic Enzyme 5\u03b1-reductase mediates psychotic-like complications of sleep deprivation","volume":"42","author":"Frau","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12996","article-title":"Allopregnanolone: an overview on its synthesis and effects","volume":"34","author":"Diviccaro","year":"2022","journal-title":"J. Neuroendocr."},{"key":"10.1016\/j.jsbmb.2025.106766_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/530121","article-title":"The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases","volume":"2012","author":"Azzouni","year":"2012","journal-title":"Adv. Urol."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib92","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/JU.0000000000001079","article-title":"Lack of association between 5\u03b1-reductase inhibitors and depression","volume":"204","author":"Dyson","year":"2020","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib93","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamainternmed.2017.0089","article-title":"Association of suicidality and depression with 5\u03b1-reductase inhibitors","volume":"177","author":"Welk","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jsbmb.2025.106766_bib94","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2016.00030","article-title":"The important roles of steroid sulfatase and sulfotransferases in gynecological diseases","volume":"7","author":"Ri\u017ener","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106766_bib95","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/cells11061038","article-title":"DHEA protects human cholangiocytes and hepatocytes against apoptosis and oxidative stress","volume":"11","author":"Kilanczyk","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","article-title":"Human sulfotransferases and their role in chemical metabolism","volume":"90","author":"Gamage","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"31","key":"10.1016\/j.jsbmb.2025.106766_bib97","doi-asserted-by":"crossref","first-page":"23496","DOI":"10.1016\/S0021-9258(19)49490-8","article-title":"Isolation of two distinct 3-hydroxysteroid sulfotransferases from the guinea pig adrenal. Evidence for 3 alpha-hydroxy versus 3 beta-hydroxy stereospecificity","volume":"268","author":"Driscoll","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106766_bib98","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1210\/edrv-17-6-670","article-title":"Steroid sulfotransferases","volume":"17","author":"Strott","year":"1996","journal-title":"Endocr. Rev."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib99","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0960-0760(92)90307-5","article-title":"Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis","volume":"43","author":"Hanukoglu","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","article-title":"The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes","volume":"60","author":"Kim","year":"2012","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yfrne.2013.05.002","article-title":"Brain and pineal 7\u03b1-hydroxypregnenolone stimulating locomotor activity: identification, mode of action and regulation of biosynthesis","volume":"34","author":"Tsutsui","year":"2013","journal-title":"Front. Neuroendocr."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1096\/fba.2019-00055","article-title":"Neuroprotective actions of cerebellar and pineal allopregnanolone on Purkinje cells","volume":"2","author":"Tsutsui","year":"2020","journal-title":"FASEB Bioadv"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib103","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00213-020-05545-5","article-title":"Psychoactive properties of BNN27, a novel neurosteroid derivate, in male and female rats","volume":"237","author":"Kokras","year":"2020","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.jsbmb.2025.106766_bib104","series-title":"Neuroactive steroids in brain function, behavior and neuropsychiatric disorders","article-title":"Dehydroepiandrosterone and Pregnenolone Alterations in Schizophrenia","author":"Ritsner","year":"2008"},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib105","first-page":"134","article-title":"Allopregnanolone and neuroinflammation: a focus on multiple sclerosis","volume":"3","author":"Noorbakhsh","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib106","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neures.2004.03.006","article-title":"Organizing actions of neurosteroids in the Purkinje neuron","volume":"49","author":"Tsutsui","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.jsbmb.2025.106766_bib107","series-title":"Steroids in the Laboratory and Clinical Practice","first-page":"63","article-title":"Chapter 1.3 - Steroid biosynthesis","author":"Honour","year":"2023"},{"key":"10.1016\/j.jsbmb.2025.106766_bib108","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2014.03.008","article-title":"Dehydroepiandrosterone: a neuroactive steroid","volume":"145","author":"St\u00e1rka","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"14","key":"10.1016\/j.jsbmb.2025.106766_bib109","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.3390\/ijms23147989","article-title":"Progesterone: a steroid with wide range of effects in physiology as well as human medicine","volume":"23","author":"Kolatorova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.seizure.2018.10.012","article-title":"Progesterone, 5a-dihydropogesterone and allopregnanolone's effects on seizures: a review of animal and clinical studies","volume":"63","author":"Wu","year":"2018","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib111","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1074\/jbc.M111.333278","article-title":"Mitochondrial 3\u03b2-hydroxysteroid dehydrogenase enzyme activity requires reversible pH-dependent conformational change at the intermembrane space","volume":"287","author":"Prasad","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib112","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ijms24010560","article-title":"Allopregnanolone: metabolism, mechanisms of action, and its role in cancer","volume":"24","author":"Zamora-S\u00e1nchez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/cells10020379","article-title":"Human placenta buffers the fetus from adverse effects of perceived maternal stress","volume":"10","author":"Vuppaladhadiam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jsbmb.2025.106766_bib114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fendo.2020.00549","article-title":"Pineal neurosteroids: biosynthesis and physiological functions","volume":"11","author":"Haraguchi","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.jsbmb.2025.106766_bib115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fncel.2014.00118","article-title":"Biosynthesis and biological action of pineal allopregnanolone","volume":"8","author":"Tsutsui","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106766_bib116","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/en.2007-1592","article-title":"Progesterone biosynthesis and action in the developing neuron","volume":"149","author":"Tsutsui","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jsbmb.2025.106766_bib118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fncel.2015.00133","article-title":"Editorial on \"New perspectives in neurosteroids action: a special player allopregnanolone\"","volume":"9","author":"Magnaghi","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106169","article-title":"Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease","volume":"183","author":"Luchetti","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jsbmb.2025.106766_bib120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2017.09.015","article-title":"Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration","volume":"174","author":"Meyer","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib121","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/cells13121063","article-title":"Non-Coding RNAs in neurological and neuropsychiatric disorders: unraveling the hidden players in disease pathogenesis","volume":"13","author":"Ilieva","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib122","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brainresrev.2007.08.010","article-title":"Regenerative potential of allopregnanolone","volume":"57","author":"Wang","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","article-title":"The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing","volume":"13","author":"Liu","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1525-1373.1999.d01-124.x","article-title":"Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action","volume":"222","author":"Cardounel","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jsbmb.2025.106766_bib125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pneurobio.2013.09.004","article-title":"Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors","volume":"113","author":"Schumacher","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.21623","article-title":"A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system","volume":"66","author":"Bateman","year":"2009","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106766_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202300461","article-title":"Enhancing the therapeutic effect in Alzheimer's disease drugs: the role of Polypharmacology and Cholinesterase inhibitors","volume":"8","author":"Martins","year":"2023","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib128","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jsbmb.2025.106766_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2009.03700.x","article-title":"Steroid hormone transforming aldo-keto reductases and cancer","volume":"1155","author":"Penning","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib130","series-title":"Cellular endocrinology in health and disease","first-page":"207","article-title":"Chapter 13 - Regulation of Steroidogenesis","author":"Bremer","year":"2014"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0197-4580(02)00048-9","article-title":"V. Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology","volume":"24","author":"Han","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jsbmb.2025.106766_bib132","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fncel.2014.00203","article-title":"Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders","volume":"8","author":"Irwin","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib133","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnagi.2019.00061","article-title":"Dehydroepiandrosterone and dehydroepiandrosterone sulfate in Alzheimer's disease: a systematic review and meta-analysis","volume":"11","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib134","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jsbmb.2013.04.002","article-title":"Neuroactive steroids in pregnancy: key regulatory and protective roles in the foetal brain","volume":"139","author":"Hirst","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2011.04.017","article-title":"The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia","volume":"191","author":"Ritsner","year":"2011","journal-title":"Neuroscience"},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106766_bib136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.steroids.2011.09.008","article-title":"Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports","volume":"77","author":"El Kihel","year":"2012","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib137","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nbd.2003.11.001","article-title":"Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid","volume":"15","author":"Dudas","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib138","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/catal13020272","article-title":"7\u03b1 and 7\u03b2 hydroxylation of dehydroepiandrosterone by Gibberella sp. and absidia coerulea biotransformation","volume":"13","author":"Song","year":"2023","journal-title":"Catalysts"},{"key":"10.1016\/j.jsbmb.2025.106766_bib139","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/ph17091186","article-title":"Dehydroepiandrosterone and its metabolite 5-androstenediol: new therapeutic targets and possibilities for clinical application","volume":"17","author":"Fedotcheva","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106766_bib140","article-title":"Influence of the onset of menopause on the risk of developing Alzheimer's disease","volume":"16","author":"Briceno","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib141","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11910-010-0122-6","article-title":"Hormonal influences on cognition and risk for Alzheimer's disease","volume":"10","author":"Janicki","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-022-01121-5","article-title":"Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort","volume":"15","author":"Saleh","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib143","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s13311-020-00874-x","article-title":"Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo: therapeutic implication for Alzheimer's disease","volume":"17","author":"Chen","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"5323","key":"10.1016\/j.jsbmb.2025.106766_bib144","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0959-9673.2005.00427.x","article-title":"Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD)","volume":"86","author":"Yan","year":"2005","journal-title":"Int. J. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib146","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41531-021-00230-6","article-title":"Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins","volume":"7","author":"Giusto","year":"2021","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.jsbmb.2025.106766_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1125962","article-title":"Progesterone exerts a neuroprotective action in a Parkinson's disease human cell model through membrane progesterone receptor \u03b1 (mPR\u03b1\/PAQR7)","volume":"14","author":"Castelnovo","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.jsbmb.2025.106766_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1464243","article-title":"Human sulfotransferase SULT2B1 physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditions","volume":"15","author":"Alherz","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.jsbmb.2025.106766_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135095","article-title":"Dehydroepiandrosterone increases tonic and phasic dopamine release in the striatum","volume":"734","author":"P\u00e9rez-Neri","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib150","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.neurobiolaging.2005.09.028","article-title":"DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys","volume":"27","author":"B\u00e9langer","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106766_bib151","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4040\/jkan.2011.41.6.834","article-title":"Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease","volume":"41","author":"Choe","year":"2011","journal-title":"J. Korean Acad. Nurs."},{"key":"10.1016\/j.jsbmb.2025.106766_bib152","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2018.04.005","article-title":"Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease","volume":"147","author":"Bourque","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106766_bib153","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1210\/en.2003-0307","article-title":"Dendritic growth and spine formation in response to estrogen in the developing Purkinje cell","volume":"144","author":"Sakamoto","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105479","article-title":"Neuroactive steroids and Parkinson's disease: review of human and animal studies","volume":"156","author":"Bourque","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.jsbmb.2025.106766_bib155","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib156","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s13555-023-00974-4","article-title":"Use of 5-alpha reductase inhibitors in dermatology: a narrative review","volume":"13","author":"Escamilla-Cruz","year":"2023","journal-title":"Dermatol. Ther. (Heide )."},{"key":"10.1016\/j.jsbmb.2025.106766_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898067","article-title":"Peripheral neuroprotective and immunomodulatory effects of 5\u03b1-reductase inhibitors in Parkinson's disease models","volume":"13","author":"Poirier","year":"2022","journal-title":"Front. Pharm."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106766_bib158","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(97)00455-1","article-title":"Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states","volume":"764","author":"Bixo","year":"1997","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib159","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.06.001","article-title":"Progesterone: therapeutic opportunities for neuroprotection and myelin repair","volume":"116","author":"Schumacher","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jsbmb.2025.106766_bib161","first-page":"447","article-title":"Cytokine control of inflammation and repair in the pathology of multiple sclerosis","volume":"85","author":"Rodgers","year":"2012","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib162","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yfrne.2011.12.001","article-title":"Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration","volume":"33","author":"Spence","year":"2012","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib163","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mehy.2010.02.028","article-title":"Influence of neurosteroids on the pathogenesis of multiple sclerosis","volume":"75","author":"Leitner","year":"2010","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib164","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-024-00742-8","article-title":"The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells","volume":"19","author":"Zveik","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jsbmb.2025.106766_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1024058","article-title":"Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis","volume":"15","author":"Voskuhl","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib166","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12502","article-title":"Neurosteroidogenesis and progesterone anti-inflammatory\/neuroprotective effects","volume":"30","author":"De Nicola","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.intimp.2017.08.007","article-title":"Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model","volume":"51","author":"Aryanpour","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.jsbmb.2025.106766_bib168","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.02.012","article-title":"Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis","volume":"159","author":"Orefice","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106766_bib170","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00424-023-02837-5","article-title":"Oligodendrocyte precursor cells: the multitaskers in the brain","volume":"475","author":"Fang","year":"2023","journal-title":"Pflug. Arch."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib171","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000353782","article-title":"Biosynthesis and biological actions of pineal neurosteroids in domestic birds","volume":"98","author":"Tsutsui","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.09.005","article-title":"Allopregnanolone: state of the art","volume":"113","author":"Melcangi","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib173","series-title":"Neuroactive steroids in brain function, behavior and neuropsychiatric disorders","article-title":"Neurosteroid Perturbation and Neuropsychiatric Symptoms in Schizophrenia: From the Mechanisms to the Treatment","author":"di Michele","year":"2008"},{"key":"10.1016\/j.jsbmb.2025.106766_bib174","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fncel.2014.00174","article-title":"Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone","volume":"8","author":"Poisbeau","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0079-6468(08)70059-6","article-title":"Development of neurosteroid-based novel psychotropic drugs","volume":"37","author":"Reddy","year":"2000","journal-title":"Prog. Med. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.04.003","article-title":"Recent developments in the significance and therapeutic relevance of neuroactive steroids--Introduction to the special issue","volume":"116","author":"Morrow","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106766_bib177","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00213-017-4649-y","article-title":"A randomized controlled trial of ganaxolone in posttraumatic stress disorder","volume":"234","author":"Rasmusson","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib178","series-title":"Dictionary of Steroids","first-page":"592","author":"Hill","year":"1991"},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106766_bib179","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nm0704-675","article-title":"Brain on steroids resists neurodegeneration","volume":"10","author":"Burns","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jsbmb.2025.106766_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.699740","article-title":"Brexanolone, a GABAA modulator, in the treatment of postpartum depression in adults: a comprehensive review","volume":"12","author":"Edinoff","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"22","key":"10.1016\/j.jsbmb.2025.106766_bib181","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3390\/molecules29225286","article-title":"LPM682000012, a synthetic neuroactive steroid that ameliorates epileptic seizures by downregulating the Serpina3n\/NF-\u03baB signaling pathway","volume":"29","author":"Zhang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2025.106766_bib182","series-title":"American College of Laboratory Animal Medicine, Anesthesia and Analgesia in Laboratory Animals","first-page":"441","article-title":"Chapter 18 - Anesthesia and analgesia in nonhuman primates","author":"Nunamaker","year":"2023"},{"key":"10.1016\/j.jsbmb.2025.106766_bib183","series-title":"American College of Laboratory Animal Medicine, Anesthesia and Analgesia in Laboratory Animals","first-page":"287","article-title":"Chapter 14 - Anesthesia and analgesia in laboratory rodents","author":"Paulin","year":"2023"},{"key":"10.1016\/j.jsbmb.2025.106766_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.541802","article-title":"Neurosteroids and Seizure Activity","volume":"11","author":"Miziak","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib185","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib186","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41386-023-01626-z","article-title":"Neurosteroids: mechanistic considerations and clinical prospects","volume":"49","author":"Maguire","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib187","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fncel.2017.00246","article-title":"Ganaxolone: a new treatment for neonatal seizures","volume":"11","author":"Yawno","year":"2017","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib188","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/epi4.12669","article-title":"The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: a meta-analysis from randomized controlled trials","volume":"8","author":"Meng","year":"2023","journal-title":"Epilepsia Open"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib189","doi-asserted-by":"crossref","first-page":"110","DOI":"10.14260\/jemds\/19","article-title":"Anti-convulsant activity of Ganaxolone alone and in comparison with standard anti-epileptic drugs in rodent models","volume":"1","author":"Subhani","year":"2012","journal-title":"J. Evol. Med. Dent. Sci."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib190","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/biom12121784","article-title":"Benzodiazepine modulation of GABA-A receptors: a mechanistic perspective","volume":"12","author":"Goldschen-Ohm","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib191","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(99)01318-8","article-title":"Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders","volume":"20","author":"Gasior","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib192","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.3390\/jcm13123567","article-title":"New pharmacological therapies in the treatment of epilepsy in the pediatric population","volume":"13","author":"Dani\u0142owska","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jsbmb.2025.106766_bib194","unstructured":"\u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-post-partum-depression?form=MG0AV3\u3009.(accessed 16 April 2025)."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-3565(24)38907-4","article-title":"Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid (A) receptors","volume":"295","author":"Vanover","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2025.106766_bib196","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40501-018-0159-8","article-title":"Neurosteroids in the pathophysiology and treatment of mood and anxiety disorders","volume":"5","author":"Perkins","year":"2018","journal-title":"Curr. Treat. Options Psych."},{"key":"10.1016\/j.jsbmb.2025.106766_bib197","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2253-10-10","article-title":"First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial","volume":"10","author":"Rigby-Jones","year":"2010","journal-title":"BMC Anesth."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib198","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1124\/jpet.102.039610","article-title":"Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo","volume":"303","author":"Visser","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib199","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/bja\/aeh125","article-title":"The interaction of anaesthetic steroids with recombinant glycine and GABA-A receptors","volume":"92","author":"Weir","year":"2004","journal-title":"Br. J. Anaesth."},{"issue":"9-10","key":"10.1016\/j.jsbmb.2025.106766_bib200","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0028-3908(96)00069-X","article-title":"The anaesthetic action and modulation of GABA-A receptor activity by the novel water-soluble aminosteroid Org 20599","volume":"35","author":"Hill-Venning","year":"1996","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib201","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/jm960733n","article-title":"Anesthetic activity of novel water-soluble 2 beta-morpholinyl steroids and their modulatory effects at GABAA receptors","volume":"40","author":"Anderson","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106766_bib202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-981-10-2155-8_17","article-title":"Antiaging neurosteroid dehydroepiandrosterone counters epileptiform activity in iron-induced experimental epilepsy","author":"Mishra","year":"2017","journal-title":"Top. Biomed. Gerontol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1298359","article-title":"Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review","volume":"14","author":"Marecki","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jsbmb.2025.106766_bib204","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jad.2023.08.027","article-title":"Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder","volume":"340","author":"Meshkat","year":"2023","journal-title":"J. Affect Disord."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106766_bib205","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/13543784.2012.703178","article-title":"Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis","volume":"21","author":"Dunkel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib206","first-page":"136","article-title":"Synthetic neuroactive steroids","volume":"45","author":"Alu\u0161\u00edk","year":"2024","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jsbmb.2025.106766_bib207","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1417938","article-title":"Golexanolone reduces glial activation in the striatum and improves non-motor and some motor alterations in a rat model of Parkinson's disease","volume":"16","author":"Izquierdo-Altarejos","year":"2024","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib208","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.expneurol.2013.07.020","article-title":"Neuroprotective action of synthetic steroids with oxygen bridge. Activity on GABA-A receptor","volume":"249","author":"Rey","year":"2013","journal-title":"Exp. Neurol."},{"issue":"1-2","key":"10.1016\/j.jsbmb.2025.106766_bib209","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(02)00214-X","article-title":"A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE","volume":"130","author":"Offner","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.arr.2003.05.001","article-title":"Pashko LL. Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity","volume":"3","author":"Schwartz","year":"2004","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106766_bib211","first-page":"838","article-title":"Current and potential pharmacologic therapies for traumatic brain injury","volume":"15","author":"Tani","year":"2022","journal-title":"Pharm. (Basel)"},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib212","first-page":"1456","article-title":"Delivery of neuroregenerative proteins to the brain for treatments of neurodegenerative brain diseases","volume":"14","author":"Ebert","year":"2024","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jsbmb.2025.106766_bib213","unstructured":"\u3008https:\/\/drugs.ncats.io\/drug\/CFS802C28F#substancescar\u3009 (accessed 16 April 2025)."},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib214","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/13543776.2019.1613374","article-title":"An updated patent review of therapeutic applications of chalcone derivatives (2014-present)","volume":"29","author":"Kar Mahapatra","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib215","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/acschemneuro.7b00303","article-title":"Studies on 16,17-pyrazoline substituted heterosteroids as Anti-Alzheimer and Anti-Parkinsonian agents using LPS induced neuroinflammation models of mice and rats","volume":"9","author":"Singh","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.jsbmb.2025.106766_bib216","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/molecules26072032","article-title":"Highlights on steroidal arylidene derivatives as a source of pharmacologically active compounds: a review","volume":"26","author":"Brito","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib217","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1073\/pnas.97.3.1202","article-title":"Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides","volume":"97","author":"Gouras","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib218","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/acschemneuro.6b00313","article-title":"Investigations on 16-arylideno steroids as a new class of neuroprotective agents for the treatment of Alzheimer's and Parkinson's diseases","volume":"8","author":"Singh","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib219","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jocn.2005.02.014","article-title":"Testosterone improves motor function in Parkinson's disease","volume":"13","author":"Mitchell","year":"2006","journal-title":"J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jsbmb.2025.106766_bib220","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1124\/mol.106.033407","article-title":"Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABA-A receptor","volume":"71","author":"Li","year":"2007","journal-title":"Mol. Pharm."},{"issue":"21","key":"10.1016\/j.jsbmb.2025.106766_bib221","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1021\/jm900468p","article-title":"Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity","volume":"52","author":"Calogeropoulou","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2025.106766_bib222","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuropharm.2016.09.007","article-title":"Selective and differential interactions of BNN27, a novel C17-spiroepoxy steroid derivative, with TrkA receptors, regulating neuronal survival and differentiation","volume":"111","author":"Pediaditakis","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jsbmb.2025.106766_bib223","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nlm.2017.03.004","article-title":"The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts delay-dependent and scopolamine-induced recognition memory deficits in rats","volume":"140","author":"Pitsikas","year":"2017","journal-title":"Neurobiol. Learn Mem."},{"issue":"10-11","key":"10.1016\/j.jsbmb.2025.106766_bib224","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kuma","year":"2000","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.113.085860","article-title":"A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation","volume":"85","author":"Dezitter","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jsbmb.2025.106766_bib226","series-title":"StatPearls [Internet]","article-title":"Methylprednisolone. 2024 Aug 11","author":"Ocejo","year":"2025"},{"key":"10.1016\/j.jsbmb.2025.106766_bib227","series-title":"StatPearls [Internet]","article-title":"Budesonide. 2023 Aug 28","author":"Kalola","year":"2025"},{"issue":"5","key":"10.1016\/j.jsbmb.2025.106766_bib228","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2165\/00003495-199550050-00006","article-title":"Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease","volume":"50","author":"Spencer","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2025.106766_bib229","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2017.12.024","article-title":"Dexamethasone inhibits inflammatory response via down regulation of AP-1 transcription factor in human lung epithelial cells","volume":"645","author":"Patil","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.jsbmb.2025.106766_bib230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00540-023-03291-4","article-title":"Neurosteroids and their potential as a safer class of general anesthetics","volume":"38","author":"Tateiwa","year":"2024","journal-title":"J. Anesth."},{"issue":"3","key":"10.1016\/j.jsbmb.2025.106766_bib231","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/biom10030443","article-title":"Succinamide derivatives ameliorate neuroinflammation and oxidative stress in scopolamine-induced neurodegeneration","volume":"10","author":"Iqbal","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jsbmb.2025.106766_bib232","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2018.00114","article-title":"Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+T cells in neurodegenerative diseases","volume":"12","author":"Solleiro-Villavicencio","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.jsbmb.2025.106766_bib233","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/antiox14040457","article-title":"Signaling pathways in oxidative stress-induced neurodegenerative diseases: a review of phytochemical therapeutic interventions","volume":"14","author":"Sebghatollahi","year":"2025","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib234","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11064-024-04281-y","article-title":"Neuroprotective potential of aminonaphthoquinone derivatives against amyloid beta-induced neuronal cell death through modulation of SIRT1 and BACE1","volume":"50","author":"Apiraksattayakul","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jsbmb.2025.106766_bib235","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.3390\/molecules27154961","article-title":"Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders","volume":"27","author":"Yousaf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2025.106766_bib236","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/antiox11020408","article-title":"Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation","volume":"11","author":"Ashok","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.jsbmb.2025.106766_bib237","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2018.00114","article-title":"Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+T cells in neurodegenerative diseases","volume":"12","author":"Solleiro-Villavicencio","year":"2018","journal-title":"Front. Cell Neurosci."},{"issue":"11","key":"10.1016\/j.jsbmb.2025.106766_bib238","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s11095-024-03790-3","article-title":"An update on recent drug delivery systems targeting brain diseases via the transnasal pathway","volume":"41","author":"Zeng","year":"2024","journal-title":"Pharm. Res"},{"key":"10.1016\/j.jsbmb.2025.106766_bib239","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.jsbmb.2025.106766_bib240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11051-021-05175-8","article-title":"Advances in dendrimer-mediated targeted drug delivery to the brain","volume":"23","author":"Gauro","year":"2021","journal-title":"J. Nanopart. Res."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib241","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/pharmaceutics15122658","article-title":"Drug delivery to the brain: recent advances and unmet challenges","volume":"15","author":"Bhunia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jsbmb.2025.106766_bib242","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fendo.2011.00055","article-title":"Neurosteroids as neuromodulators in the treatment of anxiety disorders","volume":"2","author":"Longone","year":"2011","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"23","key":"10.1016\/j.jsbmb.2025.106766_bib243","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib244","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/brainsci13020349","article-title":"Combining transcranial magnetic stimulation and deep brain stimulation: current knowledge, relevance and future perspectives","volume":"13","author":"D'Onofrio","year":"2023","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib245","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41386-023-01626-z","article-title":"Neurosteroids: mechanistic considerations and clinical prospects","volume":"49","author":"Maguire","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib246","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/jpm14121121","article-title":"The future of pharmacogenomics: integrating epigenetics, nutrigenomics, and beyond","volume":"14","author":"Shaman","year":"2024","journal-title":"J. Pers. Med."},{"issue":"12","key":"10.1016\/j.jsbmb.2025.106766_bib247","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2025.106766_bib248","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/genes11060679","article-title":"Pharmacogenomics and personalized medicine","volume":"11","author":"Cecchin","year":"2020","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.jsbmb.2025.106766_bib249","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18700\/jnc.170035","article-title":"Pharmacologic characteristics of corticosteroids","volume":"10","author":"Samuel","year":"2017","journal-title":"J. Neurocrit. Care"},{"issue":"15","key":"10.1016\/j.jsbmb.2025.106766_bib250","doi-asserted-by":"crossref","first-page":"12138","DOI":"10.3390\/ijms241512138","article-title":"Glucocorticoid treatment in acute respiratory distress syndrome: an overview on mechanistic insights and clinical benefit","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.jsbmb.2025.106766_bib251","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00415-018-8948-y","article-title":"Corticosteroids in chronic inflammatory demyelinating polyneuropathy: a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone","volume":"265","author":"van Lieverloo","year":"2018","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jsbmb.2025.106766_bib252","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments, and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2025.106766_bib253","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2024.1071","article-title":"The expanding burden of neurodegenerative diseases: an unmet medical and social need","author":"Wang","year":"2024","journal-title":"Aging Dis."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076025000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:59:29Z","timestamp":1746907169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076025000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":253,"alternative-id":["S0960076025000949"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106766","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of enzymes, neurosteroids, and synthetic steroids in neurodegenerative disorders: A critical review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106766"}}